on Fresenius SE & Co. KGaA (ETR:FRE)
Fresenius Reduces Stake in Fresenius Medical Care AG
Fresenius SE & Co. KGaA plans to sell approximately 13.4 million shares of its stake in Fresenius Medical Care AG. This sale will reduce its financial investment from around 25% to nearly 20%, via an accelerated bookbuild offering to institutional investors. The initiative aligns with Fresenius's strategy for capital redeployment under #FutureFresenius.
The company announced the action as part of its ongoing effort to manage its holdings in Fresenius Medical Care post its deconsolidation on November 30, 2023. Proceeds from the sale are intended for investments aimed at long-term growth and improving Fresenius’s financial health.
According to CEO Michael Sen, this strategic move will enable Fresenius to support growth platforms, enhancing its financial flexibility.
BNP Paribas, BofA Securities, Deutsche Bank, and J.P. Morgan are acting as joint bookrunners for the placement. Pricing details are expected before Xetra trading opens on November 12, 2026.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Fresenius SE & Co. KGaA news